Ligand Pharmaceuticals Incorporated ( LGND ) M&A Call April 27, 2026 8:00 AM EDT Company Participants Melanie Herman Todd Davis - CEO & Director Octavio Espinoza - Chief Financial Officer Lauren Hay Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division Yigal Nochomovitz - Citigroup Inc., Research Division Joseph Pantginis - H.C. Wainwright & Co, LLC, Research Division Jason Zemansky Lawrence Solow - CJS Securities, Inc. Presentation Operator Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to Ligand Pharmaceuticals to acquire XOMA Royalty. [Operator Instructions] I would now like to turn the conference over to Melanie Herman, Head of Investor Relations. Melanie, please go ahead.…